In the third plenary, Dr. Peter Mogayzel reminds us of the challenges faced in CF care, the progress we've made, and the work still ahead to meet the needs of all with cystic fibrosis and their families.
Site Search
The Robert J. Beall Award, created in 2015, recognizes members of the CF scientific community whose work embodies and carries on Beall's innovative, determined and collaborative spirit in driving advances in CF research.
Gastrointestinal issues cause serious health and quality-of-life problems for people with cystic fibrosis. That's why it was good to learn about the GI-focused research and care being done.
The recent approval of a game-changing triple-combination therapy and the announcement of a major infusion of research funding are just two reasons why we are at a pivotal time in cystic fibrosis and why this year's North American Cystic Fibrosis Conference in Nashville, Tenn., has been so exciting.
At this year's North American Cystic Fibrosis Conference in Anaheim, Calif., many of the CF Foundation's most generous and committed donors gathered to celebrate the milestones achieved over the past year in the fight against CF.
The Carolyn and C. Richard Mattingly Leadership in Mental Health Care Award honors those who are committed to the mental health of people with cystic fibrosis.
As I listened to the second plenary for this year's North American Cystic Fibrosis Conference, I couldn't help but think of my own experience with CFTR modulators and the positive effects that they have had on my health.
Finding a way to reduce lung inflammation in cystic fibrosis has challenged researchers, but we have made important advances in our understanding of this CF complication in just the last few years. Several drugs also are in development to fight another complication -- the inability to clear mucus from the lungs.
At the third plenary at this year's North American Cystic Fibrosis Conference, we explored what it means to partner in care and how to do it better.